FDA PMA
FDA Class 3
Approved
🇺🇸 United States
Drug-Eluting Peripheral Transluminal Angioplasty Catheter
PMA: P190019
·
Supplement: S038
·
Decision Jun 26, 2025
Classifications
1
FEI Numbers
26
Registration Numbers
26
Basic Information
- Device Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Trade Name
- Ranger Paclitaxel-Coated PTA Balloon Catheter
- PMA Number
- P190019
- Supplement Number
- S038
- Device Class
- FDA Class 3
- Product Code
- ONU
- Generic Name
- Drug-Eluting Peripheral Transluminal Angioplasty Catheter
- Medical Specialty
- Unknown
- Advisory Committee
- Cardiovascular
- Decision
- Approved
- Decision Code
- APPR
- Decision Date
- June 26, 2025
- Date Received
- March 21, 2025
- Supplement Type
- 135 Review Track For 30-Day Notice
- Supplement Reason
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
- Expedited Review
- N
Advisory Committee Statement
the addition of another manufacturing building and cleanroom at the same contract manufacturer facility to accommodate additional future drug coating lines
Classifications
This FDA Pre-Market Approval entry is associated with 1 FDA classification via its product code.
| Product Code | Device Name | Device Class | Medical Specialty |
|---|---|---|---|
| ONU | Drug-Eluting Peripheral Transluminal Angioplasty Catheter | FDA class 3 | Unknown |